✦ LIBER ✦

Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells

✍ Scribed by Shinji Endo; Kenji Yamato; Sachiko Hirai; Toshikazu Moriwaki; Kuniaki Fukuda; Hideo Suzuki; Masato Abei; Ichiro Nakagawa; Ichinosuke Hyodo

Book ID: 108586969
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 702 KB
Volume: 102
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2010.01821.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the antitumor effects of a

Comparison of the antitumor effects of an MDM2 inhibitor, nutlin-3, in feline lymphoma cell lines with or without p53 mutation

✍ Hiroyuki Mochizuki; Yuko Goto-Koshino; Masahiko Sato; Yasuhito Fujino; Koichi Oh 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 761 KB

Antitumor activity of the HER2 dimerizat

Antitumor activity of the HER2 dimerization inhibitor pertuzumab on human colon cancer cells in vitro and in vivo

✍ Michael Pohl; I. Stricker; A. Schoeneck; K. Schulmann; S. Klein-Scory; I. Schwar 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 457 KB

MDM2 antagonist nutlin-3 is a potent ind

MDM2 antagonist nutlin-3 is a potent inducer of apoptosis in pediatric acute lymphoblastic leukemia cells with wild-type p53 and overexpression of MDM2

✍ Gu, L; Zhu, N; Findley, H W; Zhou, M 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 280 KB

Synthesis, in vitro and in vivo evaluati

Synthesis, in vitro and in vivo evaluation of 3-arylisoquinolinamines as potent antitumor agents

✍ Su Hui Yang; Hue Thi My Van; Thanh Nguyen Le; Daulat Bikram Khadka; Suk Hee Cho; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 457 KB

In the search for potent water-soluble 3-arylisoquinolines, several 3-arylisoquinolinamines were designed and synthesized. Various substituted 3-arylisoquinolinamines exhibited strong cytotoxic activity against eight different human cancer cell lines. In particular, C-6 or C-7 dimethylamino-substitu

Antitumor effects of etodolac, a selecti

Antitumor effects of etodolac, a selective cyclooxygenase-II inhibitor, against human prostate cancer cell lines in vitro and in vivo

✍ Katsumi Shigemura; Toshiro Shirakawa; Yoshitaka Wada; Sadao Kamidono; Masato Fuj 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 217 KB

Potent in vitro and in vivo antitumor ac

Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells

✍ Hiroaki Sugiyama; Kenichiro Onuki; Kazunori Ishige; Nobue Baba; Tetsuya Ueda; Sa 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 728 KB